ethyl pyruvate has been researched along with Infarction, Middle Cerebral Artery in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, H; He, Y; Li, W; Lou, J; Wei, L; Zhang, Y | 1 |
| Kim, ID; Kim, SW; Lee, H; Lee, HK; Lee, JK; Park, JY; Yoon, SH | 1 |
| Han, PL; Jeong, JY; Kim, HJ; Kim, SW; Lee, JK; Seo, JS; Yoon, SH | 1 |
| Han, PL; Kim, JB; Kim, SY; Lee, JK; Lee, KW; Yu, YM | 1 |
| Kim, JB; Kim, SW; Lee, JK; Yu, YM | 1 |
5 other study(ies) available for ethyl pyruvate and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Ethyl pyruvate protects PC12 cells from oxygen-glucose deprivation: A potential role in ischemic cerebrovascular disease.
Topics: Animals; Apoptosis; Behavior, Animal; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; Cell Line, Tumor; Cell Survival; Gene Expression Regulation; Infarction, Middle Cerebral Artery; Injections, Intravenous; Male; Nerve Growth Factor; Nerve Tissue Proteins; Nestin; Neurons; Neuroprotective Agents; Pyruvates; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury; Specific Pathogen-Free Organisms | 2017 |
Anti-Inflammatory and Neuroprotective Effects of DIPOPA (N,N-Diisopropyl-2-Oxopropanamide), an Ethyl Pyruvate Bioisoster, in the Postischemic Brain.
Topics: Animals; Anti-Inflammatory Agents; Brain Ischemia; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Pyruvates; Rats; Rats, Sprague-Dawley | 2019 |
Combination treatment with ethyl pyruvate and aspirin enhances neuroprotection in the postischemic brain.
Topics: Animals; Aspirin; Astringents; Astrocytes; Brain Infarction; Cells, Cultured; Cerebral Cortex; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Embryo, Mammalian; Excitatory Amino Acid Agonists; Gene Expression Regulation; Glucose; Hypoxia; Infarction, Middle Cerebral Artery; Male; N-Methylaspartate; Neurons; Neuroprotective Agents; NF-kappa B; Polysaccharides; Pyruvates; Rats; Rats, Sprague-Dawley; Rotarod Performance Test; Severity of Illness Index; Time Factors; Zinc Sulfate | 2010 |
Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window.
Topics: Animals; Brain; Brain Injuries; Brain Ischemia; Coloring Agents; Cytokines; Dose-Response Relationship, Drug; Immunoblotting; Immunohistochemistry; Infarction, Middle Cerebral Artery; Inflammation; Ischemia; Lipopolysaccharides; Male; Microglia; Neuroprotective Agents; Neuropsychological Tests; Nitric Oxide; Pyruvates; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Sepsis; Tetrazolium Salts; Time Factors | 2005 |
Anti-inflammatory mechanism is involved in ethyl pyruvate-mediated efficacious neuroprotection in the postischemic brain.
Topics: Animals; Apoptosis; Brain; Cells, Cultured; Glucose; Hydrogen Peroxide; Hypoxia; Infarction, Middle Cerebral Artery; Inflammation; Male; Microglia; Neurons; Neuroprotective Agents; NF-kappa B; Oxidants; Pyruvates; Rats | 2005 |